A Montreal hospital is now offering a complimentary scalp-cooling service to all patients undergoing chemotherapy, aiming to mitigate hair loss – a common and distressing side effect of cancer treatment.
The initiative, recently launched by an unnamed hospital, provides patients with access to cooling caps during chemotherapy sessions at no cost. This marks the first instance of a hospital in the region offering the service universally to its patient base, according to reports.
The move comes as healthcare institutions in Montreal continue to advance cancer treatment protocols. Three hospitals – the McGill University Health Centre (MUHC), the Centre hospitalier de l’Université de Montréal (CHUM), and the St. Mary’s Hospital Centre (CHSM) – have collaborated on experimental treatments for lung cancer, demonstrating promising results in slowing disease progression. Details of the lung cancer research indicate a 50% improvement in outcomes compared to a control group.
The CHUM is actively involved in cancer research, with Francis Rodier, Ph.D., serving as a regular researcher in the Cancer Axis. More information on CHUM’s chemotherapy services is available on their website.
The widespread adoption of scalp cooling technology reflects a growing emphasis on patient quality of life during cancer treatment. This development could influence broader healthcare practices and potentially increase demand for similar services at other institutions.
